Methylprednisolone as adjuvant in treatment of acute respiratory distress syndrome owing to leptospirosis - A pilot study

Indian Journal of Critical Care Medicine

Volumn 9, Issue 3, 2005, Pages 133-136

  Ittyachen, Abraham ^a   Lakshmanakumar, V K ^a   Eapen, C K ^a   Joseph, M R ^a  

^a M O S C Medical College   (India)

Author keywords

ARDS; Leptospirosis; Methylprednisolone; Noninvasive ventilation

Indexed keywords

LEVOFLOXACIN; METHYLPREDNISOLONE; PENICILLIN G;

ADOLESCENT; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONVALESCENCE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LEPTOSPIROSIS; MALE; PILOT STUDY; SURVIVAL; UNIVERSITY HOSPITAL;

EID: 31844438000     PISSN: 09725229     EISSN: None     Source Type: Journal    
DOI: 10.4103/0972-5229.19677     Document Type: Article

References (15)

1. Paul NL. Leptospirosis. Clin Microbiol Rev 2001;14:296-326.
2. Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J, et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999;29:1561-3.
3. Carvalho CR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med 2002; 23:469-78.
4. Kuriakose M, Eapen CK, Paul R. Leptospirosis in Kolenchery, Kerala, India: epidemiology, prevalent local serogroups and serovars and a new serovar. Eur J Epidemiol 1997;13:691-7.
5. Rocker GM, Mackenzie MG, Williams B, Logan PM. Noninvasive positive pressure ventilation: successful outcome in patients with acute lung injury/ARDS. Chest 1999;115:173-7.
6. Kallet R.H. Evidence-based management of acute lung injury and acute respiratory distress syndrome. Respir Care 2004;49:793-809.
7. Guidelines for the Control of Leptospirosis, Geneva, World Health Organisation, 1982, WHO Offset Publication No. 67.
8. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
9. Bethlem EP, Carvalho CR. Pulmonary leptospirosis. Curr Opin Pulm Med 2000;6:436-41.
10. Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J, et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 1999;29:1561-3.
11. Carvalho CR, Bethlem EP. Pulmonary complications of leptospirosis. Clin Chest Med 2002;23:469-78.
12. Martinez Garcia MA, de Diego Damia A, Menendez Villanueva R, Lopez Hontagas JL. Pulmonary involvement in leptospirosis. Eur J Clin Microbiol Infect Dis 2000;19:471-4.
13. Silva JJ, Dalston MO, Carvalho JE, Setubal S, Oliveira JM, Pereira MM. Clinicopathological and immunohistochemical features of the severe pulmonary form of leptospirosis. Rev Soc Bras Med Trop 2002;35:395-9.
14. Friedland JS, Warrell DA. The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review. Rev Infect Dis 1991;13:207-10.
15. Umberto Meduri G, Stacey Headley A, Golden E, Carson SJ, Reba A, Umberger, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. A randomized controlled trial. JAMA 1998;280:159-65.